Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Basal Cell × Gels × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Condylomata Acuminata 3 Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Keratosis, Actinic 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Wounds and Injuries 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Parapsoriasis 1 Papillomavirus Infections 1 Non-Muscle Invasive Bladder Neoplasms 1 Non-Melanoma Skin Cancers 1 Lymphoma, Follicular 1 Keratosis, Seborrheic 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1 Fatigue 1 Exanthema 1 Eunuchism 1 Dermatitis, Contact 1

Interventions

HhAntag691 15 sonidegib 5 cemiplimab 5 Aminolevulinic Acid 5 daromun 4 Nivolumab 4 Specimen Handling 3 Radiotherapy 3 3-ingenyl angelate 3 tazarotene 2 relatlimab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 IPI-926 2 Drug Evaluation 2 Celecoxib 2 Biopsy 2 talimogene laherparepvec 1 remetinostat 1 gusacitinib 1 endonuclease V, phage T4 1 X-Rays 1 Triamcinolone 1 Sutures 1 Surgical Procedures, Operative 1 Solutions 1 Papillomavirus Vaccines 1 Opdualag 1 Observation 1 Niacinamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡